{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:51:40Z","timestamp":1790607100725,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA-DA-000635"],"award-info":[{"award-number":["ZIA-DA-000635"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA-DA000602-06"],"award-info":[{"award-number":["ZIA-DA000602-06"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["ZIA-AA000218"],"award-info":[{"award-number":["ZIA-AA000218"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01-AA023733, U24-AA020794, U01-AA020790, and U10-AA013566"],"award-info":[{"award-number":["R01-AA023733, U24-AA020794, U01-AA020790, and U10-AA013566"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41380-022-01736-y","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T01:02:28Z","timestamp":1663635748000},"page":"4642-4652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0902-4212","authenticated-orcid":false,"given":"Mehdi","family":"Farokhnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1408-7907","authenticated-orcid":false,"given":"Christopher T.","family":"Rentsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1996-8164","authenticated-orcid":false,"given":"Vicky","family":"Chuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Adrienne","family":"McGinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie K.","family":"Elvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9290-6472","authenticated-orcid":false,"given":"Eliza A.","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna E.","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5040-7966","authenticated-orcid":false,"given":"Renata C. N.","family":"Marchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan J.","family":"Tunstall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Koob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0139-5502","authenticated-orcid":false,"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-8754","authenticated-orcid":false,"given":"Lorenzo","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8829-8627","authenticated-orcid":false,"given":"Leandro F.","family":"Vendruscolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"1736_CR1","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41386-020-00950-y","volume":"46","author":"M Heilig","year":"2021","unstructured":"Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren L. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology 2021;46:1715\u20131723.","journal-title":"Neuropsychopharmacology"},{"key":"1736_CR2","doi-asserted-by":"crossref","first-page":"eaax4043","DOI":"10.1126\/sciadv.aax4043","volume":"5","author":"K Witkiewitz","year":"2019","unstructured":"Witkiewitz K, Litten RZ, Leggio L. Advances in the science and treatment of alcohol use disorder. Sci Adv. 2019;5:eaax4043.","journal-title":"Sci Adv"},{"key":"1736_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1465-3362.2008.00023.x","volume":"28","author":"G Addolorato","year":"2009","unstructured":"Addolorato G, Leggio L, Hillemacher T, Kraus T, Jerlhag E, Bleich S. Hormones and drinking behaviour: new findings on ghrelin, insulin, leptin and volume-regulating hormones. An ESBRA Symposium report. Drug Alcohol Rev. 2009;28:160\u2013165.","journal-title":"Drug Alcohol Rev"},{"key":"1736_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11065-012-9209-y","volume":"22","author":"GA Kenna","year":"2012","unstructured":"Kenna GA, Swift RM, Hillemacher T, Leggio L. The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans. Neuropsychol Rev. 2012;22:211\u2013228.","journal-title":"Neuropsychol Rev"},{"key":"1736_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","volume":"10","author":"JW Funder","year":"2005","unstructured":"Funder JW. Mineralocorticoid receptors: distribution and activation. Heart Fail Rev. 2005;10:15\u201322.","journal-title":"Heart Fail Rev"},{"key":"1736_CR6","first-page":"1163","volume":"12","author":"AM Molinari","year":"2013","unstructured":"Molinari AM, Machado-Rada MY, Mazaira GI, Erlejman AG, Galigniana MD. Molecular basis of mineralocorticoid receptor action in the nervous system. CNS Neurol Disord Drug Targets. 2013;12:1163\u20131174.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1736_CR7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejphar.2007.07.072","volume":"583","author":"M Kellner","year":"2008","unstructured":"Kellner M, Wiedemann K. Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy. Eur J Pharmacol. 2008;583:372\u2013378.","journal-title":"Eur J Pharmacol"},{"key":"1736_CR8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(00)00677-4","volume":"405","author":"JM Reul","year":"2000","unstructured":"Reul JM, Gesing A, Droste S, Stec IS, Weber A, Bachmann C, et al. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur J Pharmacol. 2000;405:235\u2013249.","journal-title":"Eur J Pharmacol"},{"key":"1736_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psyneuen.2018.09.010","volume":"105","author":"K Wingenfeld","year":"2019","unstructured":"Wingenfeld K, Otte C. Mineralocorticoid receptor function and cognition in health and disease. Psychoneuroendocrinology 2019;105:25\u201335.","journal-title":"Psychoneuroendocrinology"},{"key":"1736_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1749-6632.1994.tb39204.x","volume":"746","author":"ER de Kloet","year":"1994","unstructured":"de Kloet ER, Rots NY, van den Berg DT, Oitzl MS. Brain mineralocorticoid receptor function. Ann N Y Acad Sci. 1994;746:8\u201320.","journal-title":"Ann N Y Acad Sci"},{"key":"1736_CR11","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/npp.2011.152","volume":"36","author":"R Dorey","year":"2011","unstructured":"Dorey R, Pi\u00e9rard C, Shinkaruk S, Tronche C, Chauveau F, Baudonnat M, et al. Membrane mineralocorticoid but not glucocorticoid receptors of the dorsal hippocampus mediate the rapid effects of corticosterone on memory retrieval. Neuropsychopharmacology 2011;36:2639\u20132649.","journal-title":"Neuropsychopharmacology"},{"key":"1736_CR12","doi-asserted-by":"crossref","first-page":"e26220","DOI":"10.1371\/journal.pone.0026220","volume":"6","author":"M Zhou","year":"2011","unstructured":"Zhou M, Kindt M, Jo\u00ebls M, Krugers HJ. Blocking mineralocorticoid receptors prior to retrieval reduces contextual fear memory in mice. PLoS ONE. 2011;6:e26220.","journal-title":"PLoS ONE"},{"key":"1736_CR13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/cphy.c130044","volume":"4","author":"E Gomez-Sanchez","year":"2014","unstructured":"Gomez-Sanchez E, Gomez-Sanchez CE. The multifaceted mineralocorticoid receptor. Compr Physiol. 2014;4:965\u2013994.","journal-title":"Compr Physiol"},{"key":"1736_CR14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.biopsych.2009.04.016","volume":"66","author":"R Mitra","year":"2009","unstructured":"Mitra R, Ferguson D, Sapolsky RM. Mineralocorticoid receptor overexpression in basolateral amygdala reduces corticosterone secretion and anxiety. Biol Psychiatry. 2009;66:686\u2013690.","journal-title":"Biol Psychiatry"},{"key":"1736_CR15","doi-asserted-by":"crossref","unstructured":"de Kloet ER, Otte C, Kumsta R, Kok L, Hillegers MH, Hasselmann H, et al. Stress and depression: a crucial role of the mineralocorticoid receptor. J Neuroendocrinol. 2016;28:1\u201312.","DOI":"10.1111\/jne.12379"},{"key":"1736_CR16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tics.2015.12.003","volume":"20","author":"S Vogel","year":"2016","unstructured":"Vogel S, Fern\u00e1ndez G, Jo\u00ebls M, Schwabe L. Cognitive adaptation under stress: a case for the mineralocorticoid receptor. Trends Cogn Sci. 2016;20:192\u2013203.","journal-title":"Trends Cogn Sci"},{"key":"1736_CR17","doi-asserted-by":"crossref","first-page":"1204598","DOI":"10.1155\/2018\/1204598","volume":"2018","author":"A Cannavo","year":"2018","unstructured":"Cannavo A, Bencivenga L, Liccardo D, Elia A, Marzano F, Gambino G, et al. Aldosterone and mineralocorticoid receptor system in cardiovascular physiology and pathophysiology. Oxid Med Cell Longev. 2018;2018:1204598\u20131204598.","journal-title":"Oxid Med Cell Longev"},{"key":"1736_CR18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.alcohol.2008.03.128","volume":"42","author":"L Leggio","year":"2008","unstructured":"Leggio L, Ferrulli A, Cardone S, Miceli A, Kenna GA, Gasbarrini G, et al. Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study. Alcohol. 2008;42:375\u2013381.","journal-title":"Alcohol"},{"key":"1736_CR19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/mp.2017.97","volume":"23","author":"EG Aoun","year":"2018","unstructured":"Aoun EG, Jimenez VA, Vendruscolo LF, Walter NAR, Barbier E, Ferrulli A, et al. A relationship between the aldosterone\u2013mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans. Mol Psychiatry. 2018;23:1466\u20131473.","journal-title":"Mol Psychiatry"},{"key":"1736_CR20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF02245190","volume":"117","author":"C Fahlke","year":"1995","unstructured":"Fahlke C, H\u00e5rd E, Eriksson CJ, Engel JA, Hansen S. Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists. Psychopharmacology 1995;117:216\u2013224.","journal-title":"Psychopharmacology"},{"key":"1736_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02805986","volume":"127","author":"C Fahlke","year":"1996","unstructured":"Fahlke C, H\u00e5rd E, Hansen S. Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone. Psychopharmacology 1996;127:133\u2013139.","journal-title":"Psychopharmacology"},{"key":"1736_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brainresbull.2005.08.006","volume":"68","author":"MJ O\u2019Callaghan","year":"2005","unstructured":"O\u2019Callaghan MJ, Croft AP, Jacquot C, Little HJ. The hypothalamopituitary-adrenal axis and alcohol preference. Brain Res Bull. 2005;68:171\u2013178.","journal-title":"Brain Res Bull"},{"key":"1736_CR23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.psyneuen.2003.09.004","volume":"29","author":"HN Koenig","year":"2004","unstructured":"Koenig HN, Olive MF. The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions. Psychoneuroendocrinology. 2004;29:999\u20131003.","journal-title":"Psychoneuroendocrinology"},{"key":"1736_CR24","doi-asserted-by":"crossref","unstructured":"Tunstall BJ, Vendruscolo LF, Allen\u2013Worthington K. Chapter 26 - Rat models of alcohol use disorder. In: Suckow MA, Hankenson FC, Wilson RP, Foley PL, editors. The laboratory rat (3rd Edition). Cambridge, MA, USA: Academic Press; 2020. p. 967\u2013986.","DOI":"10.1016\/B978-0-12-814338-4.00026-X"},{"key":"1736_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1573402114666180212115518","volume":"14","author":"VA Kashkin","year":"2018","unstructured":"Kashkin VA, Shekunova EV, Egorov AY, Bagrov AY. Marinobufagenin in urine: a potential marker of predisposition to ethanol and a target for spironolactone. Curr Hypertens Rev. 2018;14:35\u201338.","journal-title":"Curr Hypertens Rev"},{"key":"1736_CR26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pbb.2018.07.011","volume":"175","author":"VH Makhijani","year":"2018","unstructured":"Makhijani VH, Van Voorhies K, Besheer J. The mineralocorticoid receptor antagonist spironolactone reduces alcohol self-administration in female and male rats. Pharmacol Biochem Behav. 2018;175:10\u201318.","journal-title":"Pharmacol Biochem Behav"},{"key":"1736_CR27","doi-asserted-by":"crossref","first-page":"108337","DOI":"10.1016\/j.neuropharm.2020.108337","volume":"181","author":"VH Makhijani","year":"2020","unstructured":"Makhijani VH, Irukulapati P, Van Voorhies K, Fortino B, Besheer J. Central amygdala mineralocorticoid receptors modulate alcohol self-administration. Neuropharmacology 2020;181:108337.","journal-title":"Neuropharmacology"},{"key":"1736_CR28","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/s41386-021-01117-z","volume":"46","author":"VA Palzes","year":"2021","unstructured":"Palzes VA, Farokhnia M, Kline-Simon AH, Elson J, Sterling S, Leggio L, et al. Effectiveness of spironolactone dispensation in reducing weekly alcohol use: a retrospective high-dimensional propensity score-matched cohort study. Neuropsychopharmacology. 2021;46:2140\u20132147.","journal-title":"Neuropsychopharmacology"},{"key":"1736_CR29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.physbeh.2004.10.007","volume":"84","author":"JS Rhodes","year":"2005","unstructured":"Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC. Evaluation of a simple model of ethanol drinking to intoxication in C57BL\/6J mice. Physiol Behav. 2005;84:53\u201363.","journal-title":"Physiol Behav"},{"key":"1736_CR30","doi-asserted-by":"crossref","first-page":"108510","DOI":"10.1016\/j.neuropharm.2021.108510","volume":"188","author":"MA McGinn","year":"2021","unstructured":"McGinn MA, Tunstall BJ, Schlosburg JE, Gregory-Flores A, George O, de Guglielmo G, et al. Glucocorticoid receptor modulators decrease alcohol self-administration in male rats. Neuropharmacology 2021;188:108510.","journal-title":"Neuropharmacology"},{"key":"1736_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331.","journal-title":"J Basic Clin Pharm"},{"key":"1736_CR32","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","volume":"158","author":"K Bush","year":"1998","unstructured":"Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158:1789\u20131795.","journal-title":"Arch Intern Med"},{"key":"1736_CR33","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/archinte.160.13.1977","volume":"160","author":"DA Fiellin","year":"2000","unstructured":"Fiellin DA, Reid MC, O\u2019Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med. 2000;160:1977\u20131989.","journal-title":"Arch Intern Med"},{"key":"1736_CR34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","volume":"163","author":"MA Brookhart","year":"2006","unstructured":"Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163:1149\u20131156.","journal-title":"Am J Epidemiol"},{"key":"1736_CR35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/aje\/kwr352","volume":"174","author":"J Pearl","year":"2011","unstructured":"Pearl J. Invited commentary: understanding bias amplification. Am J Epidemiol. 2011;174:1223\u20131227.","journal-title":"Am J Epidemiol"},{"key":"1736_CR36","unstructured":"Cormen TH. Introduction to algorithms. Cambridge, MA: MIT Press; 2009."},{"key":"1736_CR37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1162\/rest.89.2.221","volume":"89","author":"SG Donald","year":"2007","unstructured":"Donald SG, Lang K. Inference with difference-in-differences and other panel data. Rev Econ Stat. 2007;89:221\u2013233.","journal-title":"Rev Econ Stat"},{"key":"1736_CR38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1561\/0800000014","volume":"4","author":"M Lechner","year":"2011","unstructured":"Lechner M. The estimation of causal effects by difference-in-difference methods. Found Trends\u00ae Econ. 2011;4:165\u2013224.","journal-title":"Found Trends\u00ae Econ"},{"key":"1736_CR39","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083\u20133107.","journal-title":"Stat Med"},{"key":"1736_CR40","unstructured":"Understanding binge drinking. https:\/\/www.niaaa.nih.gov\/publications\/brochures-and-fact-sheets\/binge-drinking."},{"key":"1736_CR41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1073\/pnas.0503878102","volume":"103","author":"S Berger","year":"2006","unstructured":"Berger S, Wolfer DP, Selbach O, Alter H, Erdmann G, Reichardt HM, et al. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc Natl Acad Sci USA. 2006;103:195\u2013200.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1736_CR42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF00431771","volume":"87","author":"LA Grupp","year":"1985","unstructured":"Grupp LA, Elias J, Perlanski E, Stewart RB. Modification of ethanol-induced motor impairment by diet, diuretic, mineralocorticoid, or prostaglandin synthetase inhibitor. Psychopharmacology 1985;87:20\u201324.","journal-title":"Psychopharmacology"},{"key":"1736_CR43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.alcohol.2013.08.006","volume":"48","author":"LF Vendruscolo","year":"2014","unstructured":"Vendruscolo LF, Roberts AJ. Operant alcohol self-administration in dependent rats: focus on the vapor model Alcohol. 2014;48:277\u2013286.","journal-title":"Alcohol"},{"key":"1736_CR44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yfrne.2014.01.001","volume":"35","author":"EP Zorrilla","year":"2014","unstructured":"Zorrilla EP, Logrip ML, Koob GF. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol. 2014;35:234\u2013244.","journal-title":"Front Neuroendocrinol"},{"key":"1736_CR45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/bs.irn.2017.06.004","volume":"136","author":"M Roberto","year":"2017","unstructured":"Roberto M, Spierling SR, Kirson D, Zorrilla EP. Corticotropin-releasing factor (CRF) and addictive behaviors. Int Rev Neurobiol. 2017;136:5\u201351.","journal-title":"Int Rev Neurobiol"},{"key":"1736_CR46","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295\u2013300.","journal-title":"Proc R Soc Med"},{"key":"1736_CR47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10654-020-00703-7","volume":"36","author":"M Shimonovich","year":"2021","unstructured":"Shimonovich M, Pearce A, Thomson H, Keyes K, Katikireddi SV. Assessing causality in epidemiology: revisiting Bradford Hill to incorporate developments in causal thinking. Eur J Epidemiol. 2021;36:873\u2013887.","journal-title":"Eur J Epidemiol"},{"key":"1736_CR48","doi-asserted-by":"crossref","unstructured":"Meeks TW, Bekman NM, Lanouette NM, Yung KA, Vienna RP. Alcohol and alcohol use disorder. In: Ritchie EC, Llorente MD, editors. Veteran psychiatry in the US: optimizing clinical outcomes. Cham: Springer International Publishing; 2019. p. 135\u201356.","DOI":"10.1007\/978-3-030-05384-0_9"},{"key":"1736_CR49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2009.11.009","volume":"108","author":"AD Rubinsky","year":"2010","unstructured":"Rubinsky AD, Kivlahan DR, Volk RJ, Maynard C, Bradley KA. Estimating risk of alcohol dependence using alcohol screening scores. Drug Alcohol Depend. 2010;108:29\u201336.","journal-title":"Drug Alcohol Depend"},{"key":"1736_CR50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/pop.2009.0060","volume":"13","author":"AHS Harris","year":"2010","unstructured":"Harris AHS, Bradley KA, Bowe T, Henderson P, Moos R. Associations between AUDIT-C and mortality vary by age and sex. Popul Health Manag. 2010;13:263\u2013268.","journal-title":"Popul Health Manag"},{"key":"1736_CR51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(00)00545-8","volume":"405","author":"GL Kov\u00e1cs","year":"2000","unstructured":"Kov\u00e1cs GL. The role of atrial natriuretic peptide in alcohol withdrawal: a peripheral indicator and central modulator? Eur J Pharmacol. 2000;405:103\u2013112.","journal-title":"Eur J Pharmacol"},{"key":"1736_CR52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000093956","volume":"75","author":"N Sonino","year":"2006","unstructured":"Sonino N, Fallo F, Fava GA. Psychological aspects of primary aldosteronism. Psychother Psychosom. 2006;75:327\u2013330.","journal-title":"Psychother Psychosom"},{"key":"1736_CR53","doi-asserted-by":"crossref","first-page":"E878","DOI":"10.1210\/jc.2010-2723","volume":"96","author":"N Sonino","year":"2011","unstructured":"Sonino N, Tomba E, Genesia ML, Bertello C, Mulatero P, Veglio F, et al. Psychological assessment of primary aldosteronism: a controlled study. J Clin Endocrinol Metab. 2011;96:E878\u2013883.","journal-title":"J Clin Endocrinol Metab"},{"key":"1736_CR54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yhbeh.2008.02.004","volume":"54","author":"N Hlavacova","year":"2008","unstructured":"Hlavacova N, Jezova D. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm Behav. 2008;54:90\u201397.","journal-title":"Horm Behav"},{"key":"1736_CR55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/YCO.0000000000000519","volume":"32","author":"M Farokhnia","year":"2019","unstructured":"Farokhnia M, Browning BD, Leggio L. Prospects for pharmacotherapies to treat alcohol use disorder: an update on recent human studies. Curr Opin Psychiatry. 2019;32:255\u2013265.","journal-title":"Curr Opin Psychiatry"},{"key":"1736_CR56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0091-3057(96)00244-4","volume":"56","author":"JW Smythe","year":"1997","unstructured":"Smythe JW, Murphy D, Timothy C, Costall B. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats. Pharm Biochem Behav. 1997;56:507\u2013513.","journal-title":"Pharm Biochem Behav"},{"key":"1736_CR57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4530(94)00069-7","volume":"20","author":"SM Korte","year":"1995","unstructured":"Korte SM, de Boer SF, de Kloet ER, Bohus B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 1995;20:385\u2013394.","journal-title":"Psychoneuroendocrinology"},{"key":"1736_CR58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000054643","volume":"73","author":"N Calvo","year":"2001","unstructured":"Calvo N, Volosin M. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint. Neuroendocrinology 2001;73:261\u2013271.","journal-title":"Neuroendocrinology"},{"key":"1736_CR59","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1111\/bph.15511","volume":"178","author":"H Ding","year":"2021","unstructured":"Ding H, Cui SY, Cui XY, Liu YT, Hu X, Zhao HL, et al. Anti-stress effects of combined block of glucocorticoid and mineralocorticoid receptors in the paraventricular nucleus of the hypothalamus. Br J Pharmacol. 2021;178:3696\u20133707.","journal-title":"Br J Pharmacol"},{"key":"1736_CR60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1113\/jphysiol.1995.sp020698","volume":"484","author":"AG Watts","year":"1995","unstructured":"Watts AG, Sanchez-Watts G. Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone. J Physiol. 1995;484:721\u2013736.","journal-title":"J Physiol"},{"key":"1736_CR61","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09183-0","volume":"10","author":"G de Guglielmo","year":"2019","unstructured":"de Guglielmo G, Kallupi M, Pomrenze MB, Crawford E, Simpson S, Schweitzer P, et al. Inactivation of a CRF-dependent amygdalofugal pathway reverses addiction-like behaviors in alcohol-dependent rats. Nat Commun. 2019;10:1238.","journal-title":"Nat Commun"},{"key":"1736_CR62","doi-asserted-by":"crossref","unstructured":"Vendruscolo LF, Koob GF. Alcohol dependence conceptualized as a stress disorder. In: Harkness KL, Hayden EP, editors. The Oxford handbook of stress and mental health. Oxford, United Kingdom: Oxford University Press; 2020.","DOI":"10.1093\/oxfordhb\/9780190681777.013.9"},{"key":"1736_CR63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-3806(91)90111-U","volume":"61","author":"JA van Eekelen","year":"1991","unstructured":"van Eekelen JA, Bohn MC, de Kloet ER. Postnatal ontogeny of mineralocorticoid and glucocorticoid receptor gene expression in regions of the rat tel- and diencephalon. Brain Res Dev Brain Res. 1991;61:33\u201343.","journal-title":"Brain Res Dev Brain Res"},{"key":"1736_CR64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-8993(87)91555-1","volume":"436","author":"BG Yongue","year":"1987","unstructured":"Yongue BG, Roy EJ. Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: regional distribution and effects of physiological variations in serum steroids. Brain Res. 1987;436:49\u201361.","journal-title":"Brain Res"},{"key":"1736_CR65","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1172\/JCI79828","volume":"125","author":"LF Vendruscolo","year":"2015","unstructured":"Vendruscolo LF, Estey D, Goodell V, Macshane LG, Logrip ML, Schlosburg JE, et al. Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals. J Clin Investig. 2015;125:3193\u20133197.","journal-title":"J Clin Investig"},{"key":"1736_CR66","doi-asserted-by":"crossref","first-page":"T49","DOI":"10.1530\/JOE-16-0660","volume":"234","author":"M Jo\u00ebls","year":"2017","unstructured":"Jo\u00ebls M, de Kloet ER. 30 Years of the mineralocorticoid receptor: the brain mineralocorticoid receptor: a saga in three episodes. J Endocrinol. 2017;234:T49\u2013t66.","journal-title":"J Endocrinol"},{"key":"1736_CR67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00858-7","volume":"277","author":"JL Yau","year":"1999","unstructured":"Yau JL, Noble J, Seckl JR. Continuous blockade of brain mineralocorticoid receptors impairs spatial learning in rats. Neurosci Lett. 1999;277:45\u201348.","journal-title":"Neurosci Lett"},{"key":"1736_CR68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0306-4530(97)00091-7","volume":"23","author":"BR Douma","year":"1998","unstructured":"Douma BR, Korte SM, Buwalda B, la Fleur SE, Bohus B, Luiten PG. Repeated blockade of mineralocorticoid receptors, but not of glucocorticoid receptors impairs food rewarded spatial learning. Psychoneuroendocrinology 1998;23:33\u201344.","journal-title":"Psychoneuroendocrinology"},{"key":"1736_CR69","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3758\/s13415-012-0124-8","volume":"13","author":"CA Thai","year":"2013","unstructured":"Thai CA, Zhang Y, Howland JG. Effects of acute restraint stress on set-shifting and reversal learning in male rats. Cogn Affect Behav Neurosci. 2013;13:164\u2013173.","journal-title":"Cogn Affect Behav Neurosci"},{"key":"1736_CR70","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.npp.1301217","volume":"32","author":"C Otte","year":"2007","unstructured":"Otte C, Moritz S, Yassouridis A, Koop M, Madrischewski AM, Wiedemann K, et al. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology 2007;32:232\u2013238.","journal-title":"Neuropsychopharmacology"},{"key":"1736_CR71","doi-asserted-by":"crossref","unstructured":"Young KD, Preskorn SH, Victor T, Misaki M, Bodurka J, Drevets WC. The effect of mineralocorticoid and glucocorticoid receptor antagonism on autobiographical memory recall and amygdala response to implicit emotional stimuli. Int J Neuropsychopharmacol 2016;19:pyw036.","DOI":"10.1093\/ijnp\/pyw036"},{"key":"1736_CR72","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3758\/s13415-016-0441-4","volume":"16","author":"K Wingenfeld","year":"2016","unstructured":"Wingenfeld K, Kuehl LK, Dziobek I, Roepke S, Otte C, Hinkelmann K. Effects of mineralocorticoid receptor blockade on empathy in patients with major depressive disorder. Cogn Affect Behav Neurosci. 2016;16:902\u2013910.","journal-title":"Cogn Affect Behav Neurosci"},{"key":"1736_CR73","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jpsychires.2010.12.002","volume":"45","author":"MD Klok","year":"2011","unstructured":"Klok MD, Alt SR, Irurzun Lafitte AJ, Turner JD, Lakke EA, Huitinga I, et al. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J Psychiatr Res. 2011;45:871\u2013878.","journal-title":"J Psychiatr Res"},{"key":"1736_CR74","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1159\/000126180","volume":"55","author":"JR Seckl","year":"1992","unstructured":"Seckl JR, Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 1992;55:621\u2013626.","journal-title":"Neuroendocrinology"},{"key":"1736_CR75","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jpsychires.2009.10.006","volume":"44","author":"C Otte","year":"2010","unstructured":"Otte C, Hinkelmann K, Moritz S, Yassouridis A, Jahn H, Wiedemann K, et al. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J Psychiatr Res. 2010;44:339\u2013346.","journal-title":"J Psychiatr Res"},{"key":"1736_CR76","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/npp.2014.181","volume":"40","author":"C Otte","year":"2015","unstructured":"Otte C, Wingenfeld K, Kuehl LK, Kaczmarczyk M, Richter S, Quante A, et al. Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals. Neuropsychopharmacology 2015;40:386\u2013393.","journal-title":"Neuropsychopharmacology"},{"key":"1736_CR77","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1601-183X.2005.00177.x","volume":"5","author":"LF Vendruscolo","year":"2006","unstructured":"Vendruscolo LF, Terenina-Rigaldie E, Raba F, Ramos A, Takahashi RN, Morm\u00e8de P. Evidence for a female-specific effect of a chromosome 4 locus on anxiety-related behaviors and ethanol drinking in rats. Genes Brain Behav. 2006;5:441\u2013450.","journal-title":"Genes Brain Behav"},{"key":"1736_CR78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yfrne.2018.02.003","volume":"49","author":"ER de Kloet","year":"2018","unstructured":"de Kloet ER, Meijer OC, de Nicola AF, de Rijk RH, Jo\u00ebls M. Importance of the brain corticosteroid receptor balance in metaplasticity, cognitive performance and neuro-inflammation. Front Neuroendocrinol. 2018;49:124\u2013145.","journal-title":"Front Neuroendocrinol"},{"key":"1736_CR79","first-page":"650","volume":"240","author":"M de Gasparo","year":"1987","unstructured":"de Gasparo M, Joss U, Ramjou\u00e9 HP, Whitebread SE, Haenni H, Schenkel L, et al. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro. J Pharmacol Exp Ther. 1987;240:650\u2013656.","journal-title":"J Pharmacol Exp Ther"},{"key":"1736_CR80","doi-asserted-by":"crossref","first-page":"T125","DOI":"10.1530\/JOE-16-0600","volume":"234","author":"P Kolkhof","year":"2017","unstructured":"Kolkhof P, B\u00e4rfacker L. 30 Years of the mineralocorticoid receptor: mineralocorticoid receptor antagonists: 60 years of research and development. J Endocrinol. 2017;234:T125\u2013T140.","journal-title":"J Endocrinol"},{"key":"1736_CR81","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2016.02.034","volume":"1637","author":"QN Dinh","year":"2016","unstructured":"Dinh QN, Young MJ, Evans MA, Drummond GR, Sobey CG, Chrissobolis S. Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor. Brain Res. 2016;1637:146\u2013153.","journal-title":"Brain Res"},{"key":"1736_CR82","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbamem.2012.01.017","volume":"1828","author":"S Penuela","year":"2013","unstructured":"Penuela S, Gehi R, Laird DW. The biochemistry and function of pannexin channels. Biochim Biophys Acta. 2013;1828:15\u201322.","journal-title":"Biochim Biophys Acta"},{"key":"1736_CR83","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCRESAHA.117.312380","volume":"122","author":"ME Good","year":"2018","unstructured":"Good ME, Chiu Y-H, Poon IKH, Medina CB, Butcher JT, Mendu SK, et al. Pannexin 1 channels as an unexpected new target of the anti-hypertensive drug spironolactone. Circ Res. 2018;122:606\u2013615.","journal-title":"Circ Res"},{"key":"1736_CR84","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/alcalc\/agz054","volume":"54","author":"BJ Tunstall","year":"2019","unstructured":"Tunstall BJ, Lorrai I, McConnell SA, Gazo KL, Zallar LJ, de Guglielmo G, et al. Probenecid reduces alcohol drinking in rodents. is pannexin1 a novel therapeutic target for alcohol use disorder? Alcohol Alcohol. 2019;54:497\u2013502.","journal-title":"Alcohol Alcohol"},{"key":"1736_CR85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2016.10.004","volume":"130","author":"L Leggio","year":"2017","unstructured":"Leggio L, Lee MR. Treatment of alcohol use disorder in patients with alcoholic liver disease. Am J Med. 2017;130:124\u2013134.","journal-title":"Am J Med"},{"key":"1736_CR86","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/JAN.0000000000000384","volume":"32","author":"LA Farinelli","year":"2021","unstructured":"Farinelli LA, Piacentino D, Browning BD, Brewer BB, Leggio L. Cardiovascular consequences of excessive alcohol drinking via electrocardiogram: a systematic review. J Addict Nurs. 2021;32:39\u201345.","journal-title":"J Addict Nurs"},{"key":"1736_CR87","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2146\/ajhp140028","volume":"71","author":"CL Vuittonet","year":"2014","unstructured":"Vuittonet CL, Halse M, Leggio L, Fricchione SB, Brickley M, Haass-Koffler CL, et al. Pharmacotherapy for alcoholic patients with alcoholic liver disease. Am J Health Syst Pharm. 2014;71:1265\u20131276.","journal-title":"Am J Health Syst Pharm"},{"key":"1736_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2017.06.014","volume":"43","author":"A Mirijello","year":"2017","unstructured":"Mirijello A, Tarli C, Vassallo GA, Sestito L, Antonelli M, d\u2019Angelo C, et al. Alcoholic cardiomyopathy: what is known and what is not known. Eur J Intern Med. 2017;43:1\u20135.","journal-title":"Eur J Intern Med"},{"key":"1736_CR89","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.comppsych.2013.03.023","volume":"54","author":"G Martinotti","year":"2013","unstructured":"Martinotti G, Di Nicola M, Tedeschi D, Callea A, Di Giannantonio M, Janiri L. Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholics. Compr Psychiatry. 2013;54:925\u2013932.","journal-title":"Compr Psychiatry"},{"key":"1736_CR90","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.addbeh.2004.12.011","volume":"30","author":"G Addolorato","year":"2005","unstructured":"Addolorato G, Leggio L, Abenavoli L, Gasbarrini G. Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav. 2005;30:1209\u20131224.","journal-title":"Addict Behav"},{"key":"1736_CR91","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11065-008-9080-z","volume":"19","author":"L Leggio","year":"2009","unstructured":"Leggio L, Kenna GA, Fenton M, Bonenfant E, Swift RM. Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev. 2009;19:115\u2013129.","journal-title":"Neuropsychol Rev"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01736-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T11:08:45Z","timestamp":1680865725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01736-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":91,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1038\/s41380-022-01736-y","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"4 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}